Bellen Closes Series D+ Round, Led by Highlight Capital

According to VCBeat, in August 2020, Bellen Chemistry Co., Ltd. ("Bellen"), led by Highlight Capital, with additional support from Yantai Jinye Investment and Kunlun Fund. Proceeds from the financing will be used for the development of Bellen’s CRO/CDMO business and the construction of its one-stop service platform for small molecular drug R&D and synthesis.

Bellen, established in 2007, originally focused on the design and development of hundreds of novel heterocycles. Over a number of years, Bellen's innovative capabilities and reliable performance were gradually becoming more recognized in the marketplace and then the company began to develop CRO/CDMO business with its clients.

Bellen's services cover candidate molecules R&D, production process development, industrialization, large-scale processing of commercial drugs, and others, forming a professional service platform. With strong innovative capability, perfect quality management and EHS management system, and more than ten years of experience in the field of drug R&D, Bellen continues to provide quality services for well-known pharmaceutical companies and drug R&D institutions in global and has established strategic partnerships with more and more customers.

HLC is a health industry focused fund. It is dedicated to investing in leading life science enterprises that provide innovative products and services to advance diagnosis and treatment of diseases and to promote healthy living. With extensive experience, the company has established a strong presence across sub-sectors such as biotechnology (innovative therapeutics, CRO/CMO, etc.), medical technology (medical devices, IVD, etc.) and consumer health (hospital chains, personal care, etc.).

Kunlun Fund is a professional private equity fund (PEF) management institution focusing on energy services, new energy, rail transit, high-end equipment manufacturing, etc. Its headquarter is located in Beijing. After years of development, Kunlun Fund has been achieved outstanding performance in various fields.